BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2994784)

  • 1. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
    Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
    Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.
    Sullivan JL; Brewster FE; Brettler DB; Forsberg AD; Cheeseman SH; Byron KS; Baker SM; Willitts DL; Lew RA; Levine PH
    J Pediatr; 1986 Apr; 108(4):504-10. PubMed ID: 3007715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
    Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
    AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
    Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome.
    Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC
    Ann Intern Med; 1985 Oct; 103(4):545-7. PubMed ID: 2994532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.
    Gjerset GF; McGrady G; Counts RB; Martin PJ; Jason J; Kennedy S; Evatt B; Hansen JA
    Blood; 1985 Sep; 66(3):718-20. PubMed ID: 2992642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).
    Horsburgh CR; Davis KC; Hasiba U; Weiss SH; Goedert JJ; Sarin P; Kirkpatrick CH
    J Clin Immunol; 1986 Jan; 6(1):37-42. PubMed ID: 3007563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
    Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
    Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
    Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in B cell function in HTLV III/LAV positive hemophilia patients.
    Sjamsoedin-Visser EJ; Heijnen CJ; Zegers BJ; Stoop JW
    Blood; 1987 May; 69(5):1388-93. PubMed ID: 2952185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
    Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
    Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
    Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
    Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
    J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.